TGF-beta-induced Foxp3 Inhibits T(H)17 Cell Differentiation by Antagonizing RORgammat Function

Overview

Journal Nature

Specialty Science

Date 2008 Mar 28

PMID 18368049

Citations 946

Authors

Liang Zhou

Jared E Lopes

Mark M W Chong

Ivaylo I Ivanov

Roy Min

Gabriel D Victora

Yuelei Shen

Jianguang Du

Yuri P Rubtsov

Alexander Y Rudensky

Steven F Ziegler

Dan R Littman

Affiliations

Soon will be listed here.

Abstract

T helper cells that produce IL-17 (T(H)17 cells) promote autoimmunity in mice and have been implicated in the pathogenesis of human inflammatory diseases. At mucosal surfaces, T(H)17 cells are thought to protect the host from infection, whereas regulatory T (T(reg)) cells control immune responses and inflammation triggered by the resident microflora. Differentiation of both cell types requires transforming growth factor-beta (TGF-beta), but depends on distinct transcription factors: RORgammat (encoded by Rorc(gammat)) for T(H)17 cells and Foxp3 for T(reg) cells. How TGF-beta regulates the differentiation of T cells with opposing activities has been perplexing. Here we demonstrate that, together with pro-inflammatory cytokines, TGF-beta orchestrates T(H)17 cell differentiation in a concentration-dependent manner. At low concentrations, TGF-beta synergizes with interleukin (IL)-6 and IL-21 (refs 9-11) to promote IL-23 receptor (Il23r) expression, favouring T(H)17 cell differentiation. High concentrations of TGF-beta repress IL23r expression and favour Foxp3+ T(reg) cells. RORgammat and Foxp3 are co-expressed in naive CD4+ T cells exposed to TGF-beta and in a subset of T cells in the small intestinal lamina propria of the mouse. In vitro, TGF-beta-induced Foxp3 inhibits RORgammat function, at least in part through their interaction. Accordingly, lamina propria T cells that co-express both transcription factors produce less IL-17 (also known as IL-17a) than those that express RORgammat alone. IL-6, IL-21 and IL-23 relieve Foxp3-mediated inhibition of RORgammat, thereby promoting T(H)17 cell differentiation. Therefore, the decision of antigen-stimulated cells to differentiate into either T(H)17 or T(reg) cells depends on the cytokine-regulated balance of RORgammat and Foxp3.

Citing Articles

The Pathogenesis of Inflammatory Bowel Diseases.

Chauhan G, Rieder F Surg Clin North Am. 2025; 105(2):201-215.

PMID: 40015812 PMC: 11868724. DOI: 10.1016/j.suc.2024.10.008.

ACC1 is a dual metabolic-epigenetic regulator of Treg stability and immune tolerance.

Stuve P, Godoy G, Ferreyra F, Hellriegel F, Boukhallouk F, Kao Y Mol Metab. 2025; 94:102111.

PMID: 39929287 PMC: 11893314. DOI: 10.1016/j.molmet.2025.102111.

Elusive modes of Foxp3 activity in versatile regulatory T cells.

He M, Feng Y Front Immunol. 2025; 15:1533823.

PMID: 39882241 PMC: 11774722. DOI: 10.3389/fimmu.2024.1533823.

Inhibition of skin fibrosis via regulation of Th17/Treg imbalance in systemic sclerosis.

Sekiguchi A, Shimokawa C, Kato T, Uchiyama A, Yokoyama Y, Ogino S Sci Rep. 2025; 15(1):1423.

PMID: 39789188 PMC: 11717915. DOI: 10.1038/s41598-025-85895-2.

Anti-Inflammatory Effects of Clarstatin, a Shared-Epitope-Antagonistic Cyclic Peptide, on Experimental Autoimmune Uveitis in Mice.

Merzbach S, Schumacher-Klinger A, Klazas M, Hoffman A, Lazarovici P, Gilon C Invest Ophthalmol Vis Sci. 2025; 66(1):13.

PMID: 39775697 PMC: 11724373. DOI: 10.1167/iovs.66.1.13.

References

Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan A, Stroud J . FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell. 2006; 126(2):375-87. DOI: 10.1016/j.cell.2006.05.042. View

Witowski J, Ksiazek K, Jorres A . Interleukin-17: a mediator of inflammatory responses. Cell Mol Life Sci. 2004; 61(5):567-579. PMC: 11138872. DOI: 10.1007/s00018-003-3228-z. View

Sun Z, Unutmaz D, Zou Y, Sunshine M, Pierani A, Mebius R . Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science. 2000; 288(5475):2369-73. DOI: 10.1126/science.288.5475.2369. View

Aggarwal S, Ghilardi N, Xie M, de Sauvage F, Gurney A . Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem. 2002; 278(3):1910-4. DOI: 10.1074/jbc.M207577200. View

Ono M, Yaguchi H, Ohkura N, Kitabayashi I, Nagamura Y, Nomura T . Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature. 2007; 446(7136):685-9. DOI: 10.1038/nature05673. View

McKenzie B, Kastelein R, Cua D . Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 2005; 27(1):17-23. DOI: 10.1016/j.it.2005.10.003. View

Gavin M, Rasmussen J, Fontenot J, Vasta V, Manganiello V, Beavo J . Foxp3-dependent programme of regulatory T-cell differentiation. Nature. 2007; 445(7129):771-5. DOI: 10.1038/nature05543. View

Du J, Huang C, Zhou B, Ziegler S . Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3. J Immunol. 2008; 180(7):4785-92. DOI: 10.4049/jimmunol.180.7.4785. View

Lopes J, Torgerson T, Schubert L, Anover S, Ocheltree E, Ochs H . Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J Immunol. 2006; 177(5):3133-42. DOI: 10.4049/jimmunol.177.5.3133. View

10.

Korn T, Bettelli E, Gao W, Awasthi A, Jager A, Strom T . IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 2007; 448(7152):484-487. PMC: 3805028. DOI: 10.1038/nature05970. View

11.

Chen W, Jin W, Hardegen N, Lei K, Li L, Marinos N . Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003; 198(12):1875-86. PMC: 2194145. DOI: 10.1084/jem.20030152. View

12.

Duerr R, Taylor K, Brant S, Rioux J, Silverberg M, Daly M . A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006; 314(5804):1461-3. PMC: 4410764. DOI: 10.1126/science.1135245. View

13.

Lee E, Trepicchio W, Oestreicher J, Pittman D, Wang F, Chamian F . Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med. 2004; 199(1):125-30. PMC: 1887731. DOI: 10.1084/jem.20030451. View

14.

Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

15.

Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24(2):179-89. DOI: 10.1016/j.immuni.2006.01.001. View

16.

Weaver C, Harrington L, Mangan P, Gavrieli M, Murphy K . Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity. 2006; 24(6):677-688. DOI: 10.1016/j.immuni.2006.06.002. View

17.

Letterio J, Roberts A . Regulation of immune responses by TGF-beta. Annu Rev Immunol. 1998; 16:137-61. DOI: 10.1146/annurev.immunol.16.1.137. View

18.

Langrish C, Chen Y, Blumenschein W, Mattson J, Basham B, Sedgwick J . IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005; 201(2):233-40. PMC: 2212798. DOI: 10.1084/jem.20041257. View

19.

Zhou L, Ivanov I, Spolski R, Min R, Shenderov K, Egawa T . IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007; 8(9):967-74. DOI: 10.1038/ni1488. View

20.

Weaver C, Hatton R, Mangan P, Harrington L . IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007; 25:821-52. DOI: 10.1146/annurev.immunol.25.022106.141557. View